Published in J Biol Chem on January 05, 1989
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J (1993) 1.37
Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest (1994) 1.16
v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters. Biochem J (1993) 1.03
Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochem J (1994) 0.96
Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction. Biochem J (1993) 0.95
Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest (1996) 0.92
Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J (1992) 0.92
Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction. Biomolecules (2015) 0.88
Tissue-specific ceruloplasmin gene expression in the mammary gland. Biochem J (1991) 0.86
Distinct beta-subunits are present in hybrid insulin-like-growth-factor-1 receptors in the central nervous system. Biochem J (1993) 0.80
Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Afr J Tradit Complement Altern Med (2014) 0.80
Hepatic caeruloplasmin-gene expression during development in the guinea-pig. Correlation with changes in hepatic copper metabolism. Biochem J (1991) 0.79
Interaction of CCAAT/enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter. Biochem J (1993) 0.75
Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study. BMC Musculoskelet Disord (2014) 0.75
Microsomal lipid peroxidation. Methods Enzymol (1978) 16.78
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
Oxidation of persistent environmental pollutants by a white rot fungus. Science (1985) 6.52
Differential localization of two myosins within nematode thick filaments. Cell (1983) 3.84
Role of metals in oxygen radical reactions. J Free Radic Biol Med (1985) 3.22
The involvement of hydroxyl radical derived from hydrogen peroxide in lignin degradation by the white rot fungus Phanerochaete chrysosporium. J Biol Chem (1982) 2.68
Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature (1984) 2.66
Biodegradation of TNT (2,4,6-trinitrotoluene) by Phanerochaete chrysosporium. Appl Environ Microbiol (1990) 2.41
Biodegradation of pentachlorophenol by the white rot fungus Phanerochaete chrysosporium. Appl Environ Microbiol (1988) 2.40
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell (1984) 2.30
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest (1991) 2.28
Biodegradation of DDT [1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane] by the white rot fungus Phanerochaete chrysosporium. Appl Environ Microbiol (1987) 2.15
The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. J Biol Chem (1987) 2.12
Rates of ligand binding to periplasmic proteins involved in bacterial transport and chemotaxis. J Biol Chem (1983) 2.06
Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem (1999) 2.05
Biodegradation of azo and heterocyclic dyes by Phanerochaete chrysosporium. Appl Environ Microbiol (1990) 1.92
Immunological identification of the genes encoding the four myosin heavy chain isoforms of Caenorhabditis elegans. Proc Natl Acad Sci U S A (1986) 1.84
Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem (2000) 1.80
The Groucho-like transcription factor UNC-37 functions with the neural specificity gene unc-4 to govern motor neuron identity in C. elegans. Development (1997) 1.77
Myosin and paramyosin are organized about a newly identified core structure. J Cell Biol (1985) 1.76
Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem Biophys Res Commun (1974) 1.68
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve (1988) 1.57
An investigation into the mechanism of citrate-Fe2+-dependent lipid peroxidation. Free Radic Biol Med (1987) 1.56
Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest (1989) 1.53
Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem (1985) 1.51
Dynamic dead space in face masks used with noninvasive ventilators: a lung model study. Eur Respir J (2004) 1.51
Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med (1990) 1.50
UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans. Genes Dev (1999) 1.50
Results of conservative management of cervical intraepithelial neoplasia. Obstet Gynecol (1992) 1.49
Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol (1991) 1.47
Identification of myosin heavy chain in Saccharomyces cerevisiae. Nature (1985) 1.47
The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol (1998) 1.41
Pollutant degradation by white rot fungi. Rev Environ Contam Toxicol (1994) 1.40
The role of superoxide and singlet oxygen in lipid peroxidation. Photochem Photobiol (1979) 1.38
Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry (1991) 1.38
Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin. J Neurosci (2000) 1.35
Evidence for superoxide generation by NADPH-cytochrome c reductase of rat liver microsomes. Biochem Biophys Res Commun (1972) 1.32
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem (2001) 1.32
The mechanism of NADPH-dependent lipid peroxidation. The propagation of lipid peroxidation. J Biol Chem (1979) 1.30
Metastatic cystosarcoma phyllodes: a case report and review of the literature. J Surg Oncol (1972) 1.30
Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol (1993) 1.25
The kinetics of selective biological transport. IV. Assessment of three carrier systems using the erythrocyte-monosaccharide transport data. Biophys J (1968) 1.25
The mechanism of sugar binding to the periplasmic receptor for galactose chemotaxis and transport in Escherichia coli. J Biol Chem (1980) 1.25
The kinetics of selective biological transport. 3. Erythrocyte-monosaccharide transport data. Biophys J (1968) 1.23
Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler (1999) 1.23
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology (1999) 1.23
Heterologous expression of active manganese peroxidase from Phanerochaete chrysosporium using the baculovirus expression system. Biochem Biophys Res Commun (1991) 1.21
Regulation of neurotransmitter vesicles by the homeodomain protein UNC-4 and its transcriptional corepressor UNC-37/groucho in Caenorhabditis elegans cholinergic motor neurons. J Neurosci (2001) 1.19
Mechanisms white rot fungi use to degrade pollutants. Environ Sci Technol (1994) 1.19
Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter. Nucleic Acids Res (1992) 1.17
The effects of 3-methylcholanthrene and phenobarbital induction on the structure of the rat liver endoplasmic reticulum. Biochim Biophys Acta (1974) 1.17
Effect of superoxide and superoxide dismutase on lignin peroxidase-catalyzed veratryl alcohol oxidation. Arch Biochem Biophys (1994) 1.14
Microsomal electron transport. The role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J Biol Chem (1973) 1.14
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Toxicity of 3,4,5,3',4',5'-hexabrominated biphenyl and 3,4,3',4'-tetrabrominated biphenyl. Toxicol Appl Pharmacol (1985) 1.12
Paraquat toxicity: proposed mechanism of action involving lipid peroxidation. Environ Health Perspect (1976) 1.10
Veratryl alcohol oxidation by lignin peroxidase. Biochemistry (1995) 1.10
Lignin peroxidase H2 from Phanerochaete chrysosporium: purification, characterization and stability to temperature and pH. Arch Biochem Biophys (1990) 1.10
Detection of Phanerochaete chrysosporium in soil by PCR and restriction enzyme analysis. Appl Environ Microbiol (1994) 1.10
Production of hydroxyl radical by lignin peroxidase from Phanerochaete chrysosporium. Arch Biochem Biophys (1992) 1.10
Lipid peroxidation during enzymatic iodination of rat liver endoplasmic reticulum. Biochem Biophys Res Commun (1972) 1.09
The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol (1992) 1.08
The role of iron in the initiation of lipid peroxidation. Chem Phys Lipids (1987) 1.08
Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med (1986) 1.08
Ion metabolism in a halophilic blue-green alga, Aphanothece halophytica. Arch Microbiol (1976) 1.07
The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron. Biochem Biophys Res Commun (1983) 1.07
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation (1999) 1.06
The mechanism of liver microsomal lipid peroxidation. Biochim Biophys Acta (1975) 1.06
Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex. Biochemistry (1998) 1.06
Peritoneal implantation of squamous cell carcinoma following rupture of a dermoid cyst during laparoscopic removal. Gynecol Oncol (2002) 1.06
The kinetics of selective biological transport. II. Equations for induced uphill transport of sugars in human erythrocytes. Biophys J (1965) 1.05
Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol (1995) 1.05
Studies of ascorbate-dependent, iron-catalyzed lipid peroxidation. Arch Biochem Biophys (1989) 1.04
Viral inhibition of interferon signal transduction. Intervirology (1999) 1.04
Redox cycling of iron and lipid peroxidation. Lipids (1992) 1.04
Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects for protection. Am Heart J (1986) 1.03
Stabilization of the veratryl alcohol cation radical by lignin peroxidase. Biochemistry (1996) 1.03
Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter. J Biol Chem (1992) 1.03
Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol (2009) 1.03
NADPH-dependen lipid peroxidation catalyzed by purified NADPH-cytochrome C reductase from rat liver microsomes. Biochem Biophys Res Commun (1972) 1.02
Divalent transition metal cations counteract potassium-induced quadruplex assembly of oligo(dG) sequences. Nucleic Acids Res (1997) 1.01
Myosin heavy chain gene amplification as a suppressor mutation in Caenorhabditis elegans. Mol Gen Genet (1989) 1.01
Lactoperoxidase-catalyzed lipid peroxidation of microsomal and artificial membranes. Biochim Biophys Acta (1976) 1.01
Lipid peroxidation: a possible mechanism for paraquat toxicity. Res Commun Chem Pathol Pharmacol (1975) 1.00
Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol (2000) 1.00
Metabolism and detoxification of TNT by Phanerochaete chrysosporium. Biochem Biophys Res Commun (1993) 1.00
Two chemically and metabolically distinct forms of calf thymus histone F3. J Biol Chem (1972) 1.00
Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. J Biol Chem (1986) 1.00
Progress in cerebrovascular disease: local cerebral blood flow by xenon enhanced CT. Stroke (1983) 0.99
Superoxide generation by NADPH-cytochrome P-450 reductase: the effect of iron chelators and the role of superoxide in microsomal lipid peroxidation. Arch Biochem Biophys (1984) 0.98
The role of superoxide and singlet oxygen in lipid peroxidation promoted by xanthine oxidase. Biochem Biophys Res Commun (1973) 0.98
Thiol-dependent lipid peroxidation. Biochem Biophys Res Commun (1982) 0.98
Triplex formation inhibits HER-2/neu transcription in vitro. J Clin Invest (1993) 0.98
The multiple effects of ethylenediaminetetraacetate in several model lipid peroxidation systems. Arch Biochem Biophys (1982) 0.98
Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice. Am J Transplant (2007) 0.97
Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter. Biochemistry (1995) 0.96
The kinetics of selective biological transport. V. Further data on the erythrocyte-monosaccharide transport system. Biophys J (1971) 0.95
The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry (1995) 0.95
Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin. Oncogene (1995) 0.95